|
|
In 1992 in El Paso, TX a randomized, double-blind, placebo healing with magnets controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. the average ige level of the placebo treated subjects remained essentially with flat, while the average ige level for active treated subjects was reduced significantly from baseline to day 30.7 in 1993 in el paso, tx, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). the active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. the placebo group had increased symptoms in 1993. (the relevant pollen counts at the study site in 1993 were much higher than in 1992, magnets leading to expectation healing of higher symptoms.)7 in january 1997, 62 subjects who had been the placebos in the 1995 study were invited to receive the vitamin b12. in june 1997, the 62 placebo subjects were sent a questionnaire asking: how would you compare your overall allergy (hay fever) symptoms this spring to the last two springs? 20 people responded, with with 15 reporting having had the b12 treatment, and 5 not. 12 of the 15 reported at least a slight improvement in overall allergy symptoms, magnets and 1 of the 5. improvement ratios - 12:3 having received treatment, 1:4 not having received treatment.8 a bioequivalence study showed that a 3000 mcg lozenge delivered an equivalent amount healing of cyanocobalamin to the blood as a 15 mcg injection.9 with from the spring to the summer patients with demonstrated allergic rhinitis magnets received with the cyanocobalamin (or placebo) containing lozenge twice daily for 21 consecutive days. all subjects also received c and b oral multivitamins for 21 days. twice daily subjects maintained a nine-week diary on sneezing, runny nose, nasal congestion, itchy eyes, itchy nose and antihistamine (chlorpheniramine) use. in the post-treatment period, the active group (n=15) recorded on average a greater reduction in symptoms and in antihistamine healing use than the with placebo group (n=9). the results yielded reductions (0.1>p>0.01) in total weekly symptom/rescue magnets medication for the active group compared to the placebo for weeks 2, 6, 8 and 9. the results tend to replicate those of the studies on injectable cyanocobalamin.10 the high cd4/cd8 ratio and suppressed nk cell activity were healing improved by methyl-b12 treatment. the japanese with researchers state: we conclude that vitamin b12 acts as an immunomodulator for cellular immunity.11 b12 was used successfully in the treatment of ige-mediated skin disorders. the german researchers conclude that b12 (cobalamin) when applied to the skin one or more times per day exhibited ...excellent magnets results in topical treatment of skin disorders and in particular of inflammatory and hyperproliferative skin ailments and/or cutaneous manifestations of illness which are immunologic in origin, e.g. psoriasis, atopic dermatitis, contact dermatitis, and other eczematous dermatitises...12 click here for allergy medication online.
|